INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund trimming or exiting versus the previous quarter. Latest close $13.86 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Rubric Capital Management — 1 tracked fund hold IART. See all holders.
No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.
No closely related stocks by co-holding for this stock. Browse all stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Rubric Capital Management | 1.28% | 7,753,934 | HELD Q3 filed Nov 16 |
| Maverick Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -24.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 211 of 8,857 filers |
| Long-only filers among them | 211 |
| Change vs 2026 Q1 | +18 net · 208 entered · 190 exited |
| Shares reported, all filers | 73,288,672 |
| Reported value, all filers | $1.3B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus (SIC 3841) |
| Revenue · FY2025 | $1.6B |
| Net income · FY2025 | $-516.5M |
| Total assets · FY2025 | $3.6B |
| Shares outstanding | 77,800,976 |
| Market cap (at latest close) | $1.1B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.
| Shares short · Oct 15, 2026 | 7,316,999 |
| Share of shares outstanding | 9.40% |
| Days to cover | 5.52 |
Shares short at recent settlements — Jul 31, 2026: 6.5M · Aug 14, 2026: 6.7M · Aug 31, 2026: 6.9M · Sep 15, 2026: 6.8M · Sep 30, 2026: 7.3M · Oct 15, 2026: 7.3M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | PARADIGM CAPITAL MANAGEMENT INC/NY | SC 13G/A | — | — | Mar 31, 2026 | SEC filing |
| Jul 31, 2026 | Vanguard Portfolio Management | SC 13G | 3,912,816 | 5.0% | Jun 30, 2026 | SEC filing |
| May 15, 2026 | PARADIGM CAPITAL MANAGEMENT INC/NY | SC 13G | 4,012,698 | 5.2% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 17, 2026 | Fuller & Thaler Asset Management, Inc. | SC 13G/A | 3,636,359.96 | 4.7% | Dec 31, 2025 | SEC filing |
| Nov 6, 2025 | Invesco Ltd. | SC 13G/A | 3,490,908 | 4.5% | Sep 30, 2025 | SEC filing |
| Aug 5, 2025 | Morgan Stanley | SC 13G/A | 3,379,401 | 4.3% | Jun 30, 2025 | SEC filing |
| Jul 17, 2025 | BlackRock, Inc. | SC 13G/A | 10,282,705 | 13.2% | Jun 30, 2025 | SEC filing |
| Jul 9, 2025 | Rubric Capital Management LP | SC 13G/A | 7,353,934 | 9.5% | Jun 30, 2025 | SEC filing |
| May 14, 2025 | Rubric Capital Management LP | SC 13G | 4,643,672 | 6.0% | Mar 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Lobbying: 68 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Medicare/Medicaid (41), Health Issues (22), Taxation/Internal Revenue Code (10).
Federal contracts: $1.6M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $61.7K |
| FY2022 | $866.6K |
| FY2023 | $637.3K |
| FY2024 | $46.1K |
| FY2025 | $0 |
| FY2026 | $0 |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 36C24624P1850 | Department of Veterans Affairs | $432.4K | Sep 6, 2024 |
| 75N90022P00543 | Department of Health and Human Services | $418.8K | Sep 1, 2022 |
| 36C25622P1636 | Department of Veterans Affairs | $372.6K | Sep 27, 2022 |
| 36C24625P1066 | Department of Veterans Affairs | $369.1K | May 22, 2025 |
| 36C26223P1180 | Department of Veterans Affairs | $249.5K | Apr 20, 2023 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| Filed | Items | Source |
|---|---|---|
| Oct 21, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 19, 2026 | 1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 9, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Stocks A–Z · Track Record: how the signals scored · Practice timing on IART
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.